MedPal AI plc (AIM:MPAL) co-founder and CEO Jason Drummond talked with Proactive's Stephen Gunnion about the company’s strategic expansion into the online pharmacy space following its recent listing on London’s AIM market.
Drummond explained that MedPal AI’s core product is a health app that aggregates data from multiple connected devices—such as Fitbit, Apple Watch, and Oura Ring—to provide users with personalised health insights powered by artificial intelligence. The platform now integrates pharmacy capabilities through the acquisition of Universal Pharmacy, a UK-licensed distance-selling pharmacy historically dispensing around 25,000 prescriptions per month.
Drummond said the deal enables MedPal AI to “build a seamless bridge between digital insights in the app and real-world care.”
MedPal AI has also announced partnerships with Epassi and Independent Gym Network, expanding potential access to over 30 million fitness enthusiasts. Drummond added that revenue generation is expected to begin imminently.
For more exclusive interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications for future content.
#MedPalAI #JasonDrummond #DigitalHealth #AIHealthTech #UniversalPharmacy #AIMListing #WeightLossMedication #GLP1 #HealthApp #ProactiveInvestors